Yvonne Efebera, MD | oneAMYLOIDOSISvoice
×
Or register here
Global Search

Trusted Resources: People & Places

Healthcare providers, researchers, and advocates

Back to People / Healthcare Professionals
Yvonne Efebera, MD

Yvonne Efebera, MD

Healthcare Professional
Director
Blood and Marrow Transplant and Cellular Therapy
Ohio Health
3430 OhioHealth Parkway
Columbus, Ohio, United States
Yvonne Efebera serves as the Director of Blood and Marrow Transplant and Cellular Therapy at OhioHealth. She received her medical degree from Pennsylvania State University College of Medicine followed by residency in internal medicine from Cleveland Clinic Foundation Cleveland, Ohio and fellowship in Hematology/ Oncology from Boston Medical Center Boston, Massachusetts. Her areas of clinical expertise include fields like multiple myeloma, amyloidosis, graft vs host disease, Waldenstrom Macroglobulinemia, bone marrow transplantation, stem cell transplantation and blood cancers.
 
Dr. Efebera is a hematologist/oncologist and her clinical focus is B-cell lymphoid malignancies, including multiple myeloma, amyloidosis, Waldenstrom’s disease and stem cell and bone marrow transplant. 
 
Yvonne Efebera regards her patients as part of her family and every one of her patients knows they have a physician who deeply cares and has done her best to help them. She is very passionate about research, and has studied novel therapies for treating multiple myeloma and graft-versus-host disease (GVHD). 
 
 
Representative Publications:
 
 
 
view profile

Related Content

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close

Community Key Collaborator

Support for this landing page is provided by an independent education grant from

Translation of this platform made possible through an independent education grant from

© 2024 rareLife solutions Inc.

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close